ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Rehabilitation Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-30N15591
Home | Market Reports | Sensitive Subjects
Global Drug Rehabilitation Drugs Market Research Report 2023
BUY CHAPTERS

Global Drug Rehabilitation Drugs Market Research Report 2025

Code: QYRE-Auto-30N15591
Report
May 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
TEVA
Purdue Pharma
Mallinckrodt plc
Amneal Pharma
Collegium
J & J
Endo
Pfizer Inc
INSYS
Mylan NV
Hikma
Egalet

Drug Rehabilitation Drugs Market Size

The global market for Drug Rehabilitation Drugs was valued at US$ 1856 million in the year 2024 and is projected to reach a revised size of US$ 2849 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Drug Rehabilitation Drugs Market

Drug Rehabilitation Drugs Market

The development trend of detoxification drugs is mainly affected by the following aspects:
Substitution and integration of drug treatment: In drug treatment, drug substitution therapy and dry detoxification can help drug addicts successfully detoxify, but they cannot completely detoxify. Therefore, drug treatment needs to be comprehensive and diversified, including the use of different types of drug treatment, psychotherapy, behavioral therapy, etc.
Development of new detoxification drugs: With the continuous advancement of science and technology, the development of new detoxification drugs is also ongoing. These new drugs include opioid and non-opioid detoxification drugs, as well as non-drug treatments such as immunotherapy and gene therapy.
Need for personalized treatment: Everyone’s physical condition and drug withdrawal situation are different, so personalized treatment needs to be tailored to each person’s characteristics. In the future, detoxification medical institutions will pay more attention to patients" personal conditions and develop more personalized treatment plans.
Popularization and standardization of drug treatment services: As society develops and people"s understanding of the harm of drugs continues to deepen, the demand for drug treatment services will continue to increase. In the future, drug treatment services will become more popularized and standardized, and will be recognized and accepted by more people.
In short, the development trend of detoxification drugs will be towards the substitution and integration of drug treatment, the development of new detoxification drugs, the demand for personalized treatment, and the popularization and standardization of detoxification services.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Rehabilitation Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Rehabilitation Drugs.
The Drug Rehabilitation Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Rehabilitation Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Rehabilitation Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drug Rehabilitation Drugs Market Report

Report Metric Details
Report Name Drug Rehabilitation Drugs Market
Accounted market size in year US$ 1856 million
Forecasted market size in 2031 US$ 2849 million
CAGR 6.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, Hikma, Egalet
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drug Rehabilitation Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drug Rehabilitation Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Drug Rehabilitation Drugs Market growing?

Ans: The Drug Rehabilitation Drugs Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Drug Rehabilitation Drugs Market size in 2031?

Ans: The Drug Rehabilitation Drugs Market size in 2031 will be US$ 2849 million.

Who are the main players in the Drug Rehabilitation Drugs Market report?

Ans: The main players in the Drug Rehabilitation Drugs Market are Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, Hikma, Egalet

What are the Application segmentation covered in the Drug Rehabilitation Drugs Market report?

Ans: The Applications covered in the Drug Rehabilitation Drugs Market report are Hospital, Clinic

What are the Type segmentation covered in the Drug Rehabilitation Drugs Market report?

Ans: The Types covered in the Drug Rehabilitation Drugs Market report are Opioids, Non-opioid Drugs

Recommended Reports

Addiction Drug Markets

Mental Health Treatment

Other Therapeutic Drugs

1 Drug Rehabilitation Drugs Market Overview
1.1 Product Definition
1.2 Drug Rehabilitation Drugs by Type
1.2.1 Global Drug Rehabilitation Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Opioids
1.2.3 Non-opioid Drugs
1.3 Drug Rehabilitation Drugs by Application
1.3.1 Global Drug Rehabilitation Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Drug Rehabilitation Drugs Market Size Estimates and Forecasts
1.4.1 Global Drug Rehabilitation Drugs Revenue 2020-2031
1.4.2 Global Drug Rehabilitation Drugs Sales 2020-2031
1.4.3 Global Drug Rehabilitation Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drug Rehabilitation Drugs Market Competition by Manufacturers
2.1 Global Drug Rehabilitation Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drug Rehabilitation Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drug Rehabilitation Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drug Rehabilitation Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Rehabilitation Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Rehabilitation Drugs, Product Type & Application
2.7 Global Key Manufacturers of Drug Rehabilitation Drugs, Date of Enter into This Industry
2.8 Global Drug Rehabilitation Drugs Market Competitive Situation and Trends
2.8.1 Global Drug Rehabilitation Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug Rehabilitation Drugs Players Market Share by Revenue
2.8.3 Global Drug Rehabilitation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Rehabilitation Drugs Market Scenario by Region
3.1 Global Drug Rehabilitation Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drug Rehabilitation Drugs Sales by Region: 2020-2031
3.2.1 Global Drug Rehabilitation Drugs Sales by Region: 2020-2025
3.2.2 Global Drug Rehabilitation Drugs Sales by Region: 2026-2031
3.3 Global Drug Rehabilitation Drugs Revenue by Region: 2020-2031
3.3.1 Global Drug Rehabilitation Drugs Revenue by Region: 2020-2025
3.3.2 Global Drug Rehabilitation Drugs Revenue by Region: 2026-2031
3.4 North America Drug Rehabilitation Drugs Market Facts & Figures by Country
3.4.1 North America Drug Rehabilitation Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drug Rehabilitation Drugs Sales by Country (2020-2031)
3.4.3 North America Drug Rehabilitation Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Rehabilitation Drugs Market Facts & Figures by Country
3.5.1 Europe Drug Rehabilitation Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drug Rehabilitation Drugs Sales by Country (2020-2031)
3.5.3 Europe Drug Rehabilitation Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Rehabilitation Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Rehabilitation Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drug Rehabilitation Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Drug Rehabilitation Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug Rehabilitation Drugs Market Facts & Figures by Country
3.7.1 Latin America Drug Rehabilitation Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drug Rehabilitation Drugs Sales by Country (2020-2031)
3.7.3 Latin America Drug Rehabilitation Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Rehabilitation Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Rehabilitation Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drug Rehabilitation Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drug Rehabilitation Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Rehabilitation Drugs Sales by Type (2020-2031)
4.1.1 Global Drug Rehabilitation Drugs Sales by Type (2020-2025)
4.1.2 Global Drug Rehabilitation Drugs Sales by Type (2026-2031)
4.1.3 Global Drug Rehabilitation Drugs Sales Market Share by Type (2020-2031)
4.2 Global Drug Rehabilitation Drugs Revenue by Type (2020-2031)
4.2.1 Global Drug Rehabilitation Drugs Revenue by Type (2020-2025)
4.2.2 Global Drug Rehabilitation Drugs Revenue by Type (2026-2031)
4.2.3 Global Drug Rehabilitation Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Drug Rehabilitation Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drug Rehabilitation Drugs Sales by Application (2020-2031)
5.1.1 Global Drug Rehabilitation Drugs Sales by Application (2020-2025)
5.1.2 Global Drug Rehabilitation Drugs Sales by Application (2026-2031)
5.1.3 Global Drug Rehabilitation Drugs Sales Market Share by Application (2020-2031)
5.2 Global Drug Rehabilitation Drugs Revenue by Application (2020-2031)
5.2.1 Global Drug Rehabilitation Drugs Revenue by Application (2020-2025)
5.2.2 Global Drug Rehabilitation Drugs Revenue by Application (2026-2031)
5.2.3 Global Drug Rehabilitation Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Drug Rehabilitation Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Company Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Drug Rehabilitation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Teva Drug Rehabilitation Drugs Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Purdue Pharma
6.2.1 Purdue Pharma Company Information
6.2.2 Purdue Pharma Description and Business Overview
6.2.3 Purdue Pharma Drug Rehabilitation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Purdue Pharma Drug Rehabilitation Drugs Product Portfolio
6.2.5 Purdue Pharma Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Company Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Drug Rehabilitation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mallinckrodt Drug Rehabilitation Drugs Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Amneal Pharma
6.4.1 Amneal Pharma Company Information
6.4.2 Amneal Pharma Description and Business Overview
6.4.3 Amneal Pharma Drug Rehabilitation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Amneal Pharma Drug Rehabilitation Drugs Product Portfolio
6.4.5 Amneal Pharma Recent Developments/Updates
6.5 Collegium
6.5.1 Collegium Company Information
6.5.2 Collegium Description and Business Overview
6.5.3 Collegium Drug Rehabilitation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Collegium Drug Rehabilitation Drugs Product Portfolio
6.5.5 Collegium Recent Developments/Updates
6.6 J&J
6.6.1 J&J Company Information
6.6.2 J&J Description and Business Overview
6.6.3 J&J Drug Rehabilitation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 J&J Drug Rehabilitation Drugs Product Portfolio
6.6.5 J&J Recent Developments/Updates
6.7 Endo
6.7.1 Endo Company Information
6.7.2 Endo Description and Business Overview
6.7.3 Endo Drug Rehabilitation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Endo Drug Rehabilitation Drugs Product Portfolio
6.7.5 Endo Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Drug Rehabilitation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer Drug Rehabilitation Drugs Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 INSYS
6.9.1 INSYS Company Information
6.9.2 INSYS Description and Business Overview
6.9.3 INSYS Drug Rehabilitation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 INSYS Drug Rehabilitation Drugs Product Portfolio
6.9.5 INSYS Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Company Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Drug Rehabilitation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Mylan Drug Rehabilitation Drugs Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Hikma
6.11.1 Hikma Company Information
6.11.2 Hikma Description and Business Overview
6.11.3 Hikma Drug Rehabilitation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hikma Drug Rehabilitation Drugs Product Portfolio
6.11.5 Hikma Recent Developments/Updates
6.12 Egalet
6.12.1 Egalet Company Information
6.12.2 Egalet Description and Business Overview
6.12.3 Egalet Drug Rehabilitation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Egalet Drug Rehabilitation Drugs Product Portfolio
6.12.5 Egalet Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Rehabilitation Drugs Industry Chain Analysis
7.2 Drug Rehabilitation Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Rehabilitation Drugs Production Mode & Process Analysis
7.4 Drug Rehabilitation Drugs Sales and Marketing
7.4.1 Drug Rehabilitation Drugs Sales Channels
7.4.2 Drug Rehabilitation Drugs Distributors
7.5 Drug Rehabilitation Drugs Customer Analysis
8 Drug Rehabilitation Drugs Market Dynamics
8.1 Drug Rehabilitation Drugs Industry Trends
8.2 Drug Rehabilitation Drugs Market Drivers
8.3 Drug Rehabilitation Drugs Market Challenges
8.4 Drug Rehabilitation Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
TEVA
Purdue Pharma
Mallinckrodt plc
Amneal Pharma
Collegium
J & J
Endo
Pfizer Inc
INSYS
Mylan NV
Hikma
Egalet
List of Tables
 Table 1. Global Drug Rehabilitation Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Drug Rehabilitation Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Drug Rehabilitation Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Drug Rehabilitation Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Drug Rehabilitation Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Drug Rehabilitation Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Drug Rehabilitation Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Drug Rehabilitation Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Drug Rehabilitation Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Drug Rehabilitation Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Drug Rehabilitation Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Drug Rehabilitation Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drug Rehabilitation Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Rehabilitation Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drug Rehabilitation Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Drug Rehabilitation Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Drug Rehabilitation Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Drug Rehabilitation Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Drug Rehabilitation Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Drug Rehabilitation Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Drug Rehabilitation Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Drug Rehabilitation Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Drug Rehabilitation Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Drug Rehabilitation Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Drug Rehabilitation Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Drug Rehabilitation Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Drug Rehabilitation Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Drug Rehabilitation Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Drug Rehabilitation Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Drug Rehabilitation Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Drug Rehabilitation Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Drug Rehabilitation Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Drug Rehabilitation Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Drug Rehabilitation Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Drug Rehabilitation Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Drug Rehabilitation Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Drug Rehabilitation Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Drug Rehabilitation Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drug Rehabilitation Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Drug Rehabilitation Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Drug Rehabilitation Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Drug Rehabilitation Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Drug Rehabilitation Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Drug Rehabilitation Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Drug Rehabilitation Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Drug Rehabilitation Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Drug Rehabilitation Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Drug Rehabilitation Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Drug Rehabilitation Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Drug Rehabilitation Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Drug Rehabilitation Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Drug Rehabilitation Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Drug Rehabilitation Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Drug Rehabilitation Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Drug Rehabilitation Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Drug Rehabilitation Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Drug Rehabilitation Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Drug Rehabilitation Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Drug Rehabilitation Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Drug Rehabilitation Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Drug Rehabilitation Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Drug Rehabilitation Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Drug Rehabilitation Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Drug Rehabilitation Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Drug Rehabilitation Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Drug Rehabilitation Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Drug Rehabilitation Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Drug Rehabilitation Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Teva Company Information
 Table 71. Teva Description and Business Overview
 Table 72. Teva Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Teva Drug Rehabilitation Drugs Product
 Table 74. Teva Recent Developments/Updates
 Table 75. Purdue Pharma Company Information
 Table 76. Purdue Pharma Description and Business Overview
 Table 77. Purdue Pharma Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Purdue Pharma Drug Rehabilitation Drugs Product
 Table 79. Purdue Pharma Recent Developments/Updates
 Table 80. Mallinckrodt Company Information
 Table 81. Mallinckrodt Description and Business Overview
 Table 82. Mallinckrodt Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Mallinckrodt Drug Rehabilitation Drugs Product
 Table 84. Mallinckrodt Recent Developments/Updates
 Table 85. Amneal Pharma Company Information
 Table 86. Amneal Pharma Description and Business Overview
 Table 87. Amneal Pharma Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Amneal Pharma Drug Rehabilitation Drugs Product
 Table 89. Amneal Pharma Recent Developments/Updates
 Table 90. Collegium Company Information
 Table 91. Collegium Description and Business Overview
 Table 92. Collegium Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Collegium Drug Rehabilitation Drugs Product
 Table 94. Collegium Recent Developments/Updates
 Table 95. J&J Company Information
 Table 96. J&J Description and Business Overview
 Table 97. J&J Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. J&J Drug Rehabilitation Drugs Product
 Table 99. J&J Recent Developments/Updates
 Table 100. Endo Company Information
 Table 101. Endo Description and Business Overview
 Table 102. Endo Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Endo Drug Rehabilitation Drugs Product
 Table 104. Endo Recent Developments/Updates
 Table 105. Pfizer Company Information
 Table 106. Pfizer Description and Business Overview
 Table 107. Pfizer Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Pfizer Drug Rehabilitation Drugs Product
 Table 109. Pfizer Recent Developments/Updates
 Table 110. INSYS Company Information
 Table 111. INSYS Description and Business Overview
 Table 112. INSYS Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. INSYS Drug Rehabilitation Drugs Product
 Table 114. INSYS Recent Developments/Updates
 Table 115. Mylan Company Information
 Table 116. Mylan Description and Business Overview
 Table 117. Mylan Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Mylan Drug Rehabilitation Drugs Product
 Table 119. Mylan Recent Developments/Updates
 Table 120. Hikma Company Information
 Table 121. Hikma Description and Business Overview
 Table 122. Hikma Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Hikma Drug Rehabilitation Drugs Product
 Table 124. Hikma Recent Developments/Updates
 Table 125. Egalet Company Information
 Table 126. Egalet Description and Business Overview
 Table 127. Egalet Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Egalet Drug Rehabilitation Drugs Product
 Table 129. Egalet Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Drug Rehabilitation Drugs Distributors List
 Table 133. Drug Rehabilitation Drugs Customers List
 Table 134. Drug Rehabilitation Drugs Market Trends
 Table 135. Drug Rehabilitation Drugs Market Drivers
 Table 136. Drug Rehabilitation Drugs Market Challenges
 Table 137. Drug Rehabilitation Drugs Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug Rehabilitation Drugs
 Figure 2. Global Drug Rehabilitation Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug Rehabilitation Drugs Market Share by Type: 2024 & 2031
 Figure 4. Opioids Product Picture
 Figure 5. Non-opioid Drugs Product Picture
 Figure 6. Global Drug Rehabilitation Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Drug Rehabilitation Drugs Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Drug Rehabilitation Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Drug Rehabilitation Drugs Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Drug Rehabilitation Drugs Sales (2020-2031) & (K Units)
 Figure 13. Global Drug Rehabilitation Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 14. Drug Rehabilitation Drugs Report Years Considered
 Figure 15. Drug Rehabilitation Drugs Sales Share by Manufacturers in 2024
 Figure 16. Global Drug Rehabilitation Drugs Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Drug Rehabilitation Drugs Players: Market Share by Revenue in Drug Rehabilitation Drugs in 2024
 Figure 18. Drug Rehabilitation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Drug Rehabilitation Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Drug Rehabilitation Drugs Sales Market Share by Country (2020-2031)
 Figure 21. North America Drug Rehabilitation Drugs Revenue Market Share by Country (2020-2031)
 Figure 22. United States Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Drug Rehabilitation Drugs Sales Market Share by Country (2020-2031)
 Figure 25. Europe Drug Rehabilitation Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Drug Rehabilitation Drugs Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Drug Rehabilitation Drugs Revenue Market Share by Region (2020-2031)
 Figure 33. China Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Drug Rehabilitation Drugs Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Drug Rehabilitation Drugs Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Drug Rehabilitation Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Drug Rehabilitation Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Drug Rehabilitation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Drug Rehabilitation Drugs by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Drug Rehabilitation Drugs by Type (2020-2031)
 Figure 52. Global Drug Rehabilitation Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Drug Rehabilitation Drugs by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Drug Rehabilitation Drugs by Application (2020-2031)
 Figure 55. Global Drug Rehabilitation Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 56. Drug Rehabilitation Drugs Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Drug Addiction Treatment Market Research Report 2024
Global Women s Health Care Drugs Market Research Report 2024
Global Nutritional Vitamin Drugs Market Research Report 2024
Global Toxicity Testing Outsourcing Market Research Report 2024
Global Overactive Bladder Medication Market Insights Forecast to 2030
Global Detox Product Market Insights Forecast to 2030
Global Pain Treatment Drug Market Research Report 2025
Global Toxicological Testing Market Research Report 2024
Global Drugs for Pain Management Market Insights Forecast to 2030
Global Substance Abuse EMR Software Market Insights Forecast to 2030
Global Warfarin Market Insights Forecast to 2030
Global Rheumatic Disorders Drug Market Insights Forecast to 2030
Global Gynecological Conditions Medications Market Research Report 2024
Global Menopausal Medications Market Research Report 2024
Global Pain Treatment Medication Market Research Report 2025
Global Pain Management Drugs Market Research Report 2025
Pet Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric Medicines Market Research Report 2024
Global Hair Drug Testing Service Market Insights Forecast to 2030
Global Psychological Rehabilitation Service Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions